<DOC>
	<DOCNO>NCT00780728</DOCNO>
	<brief_summary>This study examine effect add-on sildenafil bosentan monotherapy patient Pulmonary Arterial Hypertension . Patients bosentan monotherapy follow every 6 month assess meet pre-defined treatment goal . If patient fails achieve treatment goal fail maintain , sildenafil add exist bosentan monotherapy . Patients assess 6 month start combination therapy change 6MWT , Borg dyspnea scale , WHO functional class , quality life .</brief_summary>
	<brief_title>Study Evaluating Addition Sildenafil Bosentan Therapy Pulmonary Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>Inclusion &amp; Exclusion Criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>